The 2025 American Society of Clinical Oncology (ASCO) Gastrointestinal (GI) Cancers Symposium will be held from Thursday, January 23 to Saturday, January 25, 2025, at Moscone West in San Francisco, CA. This symposium serves as an important platform for staying abreast of the most recent advancements in research and gaining insights from leading experts on […]
Read More
Today, we will be looking into the latest research and clinical trials focused on ulcerative colitis in adults. The following list has been carefully curated by evaluating the ongoing Phase 3 trials for moderately to severe ulcerative colitis, specifically targeting adults in the United States. Please note that the dates provided are approximate and subject […]
Read More
Today, we will be looking into the latest research and clinical trials focused on Crohn’s disease in adults. The following list has been carefully curated by evaluating the ongoing Phase 3 trials for Crohn’s disease, specifically targeting adults in the United States. Please note that the dates provided are approximate and subject to change. This […]
Read More
Ulcerative colitis (UC) impacts nearly 2 million individuals in the United States. This chronic inflammatory bowel disease typically emerges in early adulthood and follows a pattern of relapsing and remitting symptoms. Unfortunately, up to 20% of patients may eventually require colectomy, and 33% may need hospitalization for disease management. Effectively controlling inflammatory activity is essential […]
Read More
In this edition of our Guideline Spotlight, we will explore the key insights and takeaways from the American Society of Clinical Oncology’s (ASCO) comprehensive guideline, Systemic Therapy for Tumor Control in Metastatic Well-differentiated Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs). This guideline offers evidence-based recommendations for the treatment of advanced or metastatic GEP-NETs, a rare group of tumors […]
Read More
Constipation is a prevalent gastrointestinal disorder, affecting approximately 15% of the global population. It is more commonly diagnosed in North America and Europe compared to Asia, likely due to variations in diet, culture, and environment. Risk factors for constipation include age over 65, female gender, sedentary lifestyle, low socioeconomic status, low-fiber diet, and non-White race. […]
Read More
The American College of Gastroenterology’s Annual Scientific Meeting and Postgraduate Course, ACG 2024, took place in Philadelphia, PA from October 25-30, 2024. This esteemed event was designed to address the educational needs and priorities of clinical GI practitioners, showcasing the latest advancements in clinical GI, hepatology, and endoscopy. During ACG 2024, several key abstracts were […]
Read More
In this installment of our Guidelines Timelines Series, we will be conducting a comparative analysis of the American College of Gastroenterology’s (ACG) 2024 guideline on Alcohol-Associated Liver Disease in contrast to their previous 2018 version. Alcohol-associated liver disease (ALD) stands as a prominent cause of preventable liver-related morbidity and mortality on a global scale, including […]
Read MoreWelcome to the latest installment of our Guidelines+ Monographs Series. In this edition, we will delve into the medication vedolizumab, marketed under the brand name Entyvio by Takeda Pharmaceuticals. Entyvio is an integrin receptor antagonist indicated in adults for the treatment of moderately to severely active ulcerative colitis (UC) and moderately to severely active Crohn’s […]
Read More
Pompe disease, also known as acid maltase disease and glycogen storage disease II, is a rare genetic disorder that results in progressive weakness in the heart and skeletal muscles. This debilitating condition is caused by mutations in a gene responsible for producing an enzyme called acid alpha-glucosidase (GAA). This enzyme plays a crucial role in […]
Read More